v3.19.1
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Operating expenses:    
Research and development $ 4,368,784 $ 4,756,468
General and administrative 12,881,027 8,138,117
Depreciation 12,403 11,698
Total operating expenses 17,262,214 12,906,283
Loss from operations (17,262,214) (12,906,283)
Other income (expense):    
Gain on change in fair value of derivatives 0 210,465
Interest income 10,897 75
Loss before income taxes (17,251,317) (12,695,743)
Income taxes (benefit) 0 0
Net loss (17,251,317) (12,695,743)
Preferred stock dividend (884,736) (119,877)
NET LOSS AVAILABLE TO COMMON STOCKHOLDERS $ (18,136,053) $ (12,815,620)
Net loss per common share, basic and diluted (in Dollars per share) $ (1.25) $ (1.25)
Weighted average number of common shares outstanding, basic and diluted (in Shares) 14,504,360 10,220,275

Source